Nitric oxide donors as potential additions to anti-alopecia areata armamentarium

Inflammation Research

Volumn 52, Issue 6, 2003, Pages 227-229

  Namazi, M R ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alopecia areata; Calcitonin gene related peptide; Contact dermatitis; Helper T cell; Mechanism; Nitric oxide; Treatment

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE;

ALOPECIA AREATA; CONTACT DERMATITIS; HUMAN; IMMUNOREGULATION; PATHOGENESIS; REVIEW; TH1 CELL; TH2 CELL;

EID: 0038723714     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-003-1175-7     Document Type: Review

References (24)

1. Dover JS. Pocket Guide to Cutaneous Medicine and Surgery. Pennsylvania: W.B. Saunders Company 1996; 493-4.
2. Randall VA. Is alopecia areata an autoimmune disease? Lancet 2001; 358: 1922-8.
3. Nickoloff BJ, Griffiths CEM. Aberrant intercellular adhesion molecule-1 (ICAM-1) expression by hair-follicle epithelial cells and endothelial leukocyte adhesion molecule-1 (ELAM-1) by vascular cells are important adhesion-molecular alterations in alopecia areata. J Invest Dermatol 1991; 96: 91S-2S.
4. Hoffman R, Wenzel E, Huth A, Steen P, Schaufele M, Henninger HP. Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphencyprone. J Invest Dermatol 1994; 103: 530-3
5. Namazi MR. The potential effectiveness of thalidomide in the treatment of recalcitrant alopecia areata. Med Hypotheses (In Press).
6. Teraki Y, Imanishi K, Shiohara T. Cytokines in alopecia areata: contrasting cytokine profiles in localized form and extensive form (alopecia universalis) Acta Dermatol Venereol (Stockh) 1996; 76: 421-3.
7. Hodinsky M, Lorimer S, Ericson Worel S. Innervation and vasculature of the normal human and alopecia areata (AA) hair follicle: an immunohistochemical, laser scanning confocal microscope study. In: Van Neste D, Randall VA, eds. Hair Research for the Next Millennium. Amsterdam: Elsevier 1996; 197-202.
8. Rossi R, Del Bianco E, Isolani D, Baccari MC, Cappugi P. Possible involvement of neuropeptidergic sensory nerves in alopecia areata. Neuroreport 1997; 8: 1135-8.
9. Daly TJ. Alopecia areata has low plasma levels of the vasodilator/immunomodulator calacitonin gene-related peptide. Arch Dermatol 1998; 134: 1164-5.
10. Hosoi J, Murphy GF, Egan CL, Lerner EA, Grabbe S, Asahina A et al. Regulation of Langerhans' cell function by nerves containing calcitonin gene-related peptide. Nature 1993; 363: 159-63.
11. Anggard E. Nitric oxide: mediator, murderer, and medicine [see comments]. Lancet 1994; 343: 1199-206.
12. Weller R. Nitric oxide-a newly discovered chemical transmitter in human skin. Br J Dermatol 1997; 137: 665-72.
13. Sicher SC, Vazques MA, Lu CY. Inhibition of macrophage Ia expression by nitric oxide. J Immunol 1994; 153: 1293-300.
14. Habib A, Bernard C, Lebret M, Creminon C, Esposito B, Tedgui A et al. Regulation of the expression of cyclo-oxygenase 2 by nitric oxide in rat peritoneal macrophages. J Immunol 1997; 158: 3845-51.
15. 2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol 1993; 150: 5321-9.
16. 2 control of T cell cytokine production is functionally related to the reduced lymphocyte proliferation in atopic dermatitis. J Allergy Clin Immunol 1996; 97: 58-94.
17. Kolb H, Kolb-Bachofen V. Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator. Immunol Today 1998; 19: 556-61.
18. Strecker T, Dux M, Messlinger K. Increase in meningeal blood flow by nitric oxide interaction with calcitonin gene-related peptide receptor and prostaglandin synthesis inhibition. Cephalalgia 2002; 22: 233-41.
19. Lul F, Fiscus RR. Nitric oxide donors enhance calcitonin gene-related peptide-induced elevations of cyclic AMP in vascular smooth muscle cells. Eur J Pharmacol 1999; 376: 307-14.
20. Ormerod AD, Dwyer CM, Reid A, Copeland P, Thompson WD. Inducible nitric oxide synthase demonstrated in allergic and irritant contact dermatitis. Acta Derm Venerol (Stockh) 1997; 77: 436-40.
21. Ross R, Reske-Kunz AB. The role of NO in contact hypersensitivity. Int Immunopharmacol 2001; 1: 1469-78.
22. Sahin S, Onder M, Sancok B, Bukan N, Gurer MA. The role of nitric oxide in allergic contact dermatitis. Arch Dermatol Res 2001; 293: 214-7.
23. Stewart MI, Smoller BR. Alopecia universalis in an HIV-positive patient: possible insight into the pathogenesis. J Cutan Pathol 1993; 20: 180-3
24. Pretraforte D, Tritarelli E, Testa U, Minetti M. gp 120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J Leukoc Biol 1994; 55: 175-82.